[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cadherin-17":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Cadherin-17",4,3,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07066657","A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:17:45.190188Z","2026-07-30T01:46:14.415478Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06055439","A Phase 1\u002F2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:54.586325Z","2026-05-05T02:35:31.753376Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07529808","Phase 1\u002F2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma",[20],"2026-08-26T02:17:29.353236Z","2026-07-19T19:36:05.142219Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT07693751","A Study Testing SOT109 for the First Time in Patients, to Assess How Safe SOT109 is, How Well it Works, and How the Body Handles it in Patients With Advanced Colorectal Cancer That Can Not be Removed by Surgery or is Metastatic",[20],"NOT_YET_RECRUITING","2026-08-26T02:16:18.872924Z","2026-07-19T19:36:05.174938Z"]